Abstract
Stenotrophomonas maltophilia is gaining importance as a community-acquired pathogen, after becoming firmly established as a nosocomial pathogen. Here we report a case of endogenous endophthalmitis due to S. maltophilia. Antibiotic-susceptibility testing of the isolate was performed by the Kirby-Bauer disc diffusion method. The organism was resistant to aminoglycosides, imipenem, ticarcillin and cotrimoxazole and was sensitive to ceftazidime and chloramphenicol. The patient was successfully treated with a sensitivity-based intravitreal antibiotic regimen.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Bacterial Agents / therapeutic use*
-
Drug Resistance, Bacterial
-
Endophthalmitis* / drug therapy
-
Endophthalmitis* / microbiology
-
Endophthalmitis* / pathology
-
Gram-Negative Bacterial Infections* / drug therapy
-
Gram-Negative Bacterial Infections* / microbiology
-
Gram-Negative Bacterial Infections* / pathology
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Stenotrophomonas maltophilia / drug effects
-
Stenotrophomonas maltophilia / pathogenicity*
-
Treatment Outcome